In 2020, Zoyes sold 100% of dilutive convertible note to Marquis on 12/7, Wildermuth resigned on 12/8, Feldenkrais took over on 12/22. Feldenkrais received 5 series A shares on 12/27.
Maybe Zoyes assumed CEO role in that period after Wildermuth resigned.